AUPH - Aurinia Pharmaceuticals' (AUPH) CEO Peter Greenleaf on Q3 2021 Results - Earnings Call Transcript

Aurinia Pharmaceuticals Inc. (AUPH) Q3 2021 Earnings Conference Call November 03, 2021 8:30 AM ET Company Participants Dana Lynch – Investor Relations and Corporate Communications Peter Greenleaf – President and Chief Executive Officer Joe Miller – Chief Financial Officer Max Colao – Chief Commercial Officer Neil Solomons – Chief Medical Officer Conference Call Participants Alethia Young – Cantor Fitzgerald Ed Arce – H.C. Wainwright and Company Farzin Haque – Jefferies Ken Cacciatore – Cowen and Company Joseph Schwartz – SVB Leerink Justin Kim – Oppenheimer and Company David Martin – Bloom Burton Doug Miehm – RBC Capital Markets Presentation Operator Greetings, and welcome to Aurinia Pharmaceuticals Third Quarter 2021 Results Conference Call. At this time all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. I would now like to turn the conference over to

For further details see:

Aurinia Pharmaceuticals' (AUPH) CEO Peter Greenleaf on Q3 2021 Results - Earnings Call Transcript